Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
4(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
6
75%
Ph phase_2
2
25%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(2)
Other(2)

Detailed Status

Recruiting3
Completed2
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
4
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (25.0%)
N/A6 (75.0%)

Trials by Status

active_not_recruiting113%
recruiting338%
completed225%
unknown225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
PROCEDURE
Total Trials
8